Literature DB >> 8120413

Epithelial-stromal interactions in basal cell cancer: the PDGF system.

F Pontén1, Z Ren, M Nistér, B Westermark, J Pontén.   

Abstract

A proposed progenitor cell for basal cell carcinoma is a stem cell located in the bulge of the hair follicle. Previous investigations have shown that basal cell carcinoma has a specific stroma requirement for its growth. Likewise the development of a normal hair follicle requires the inductive force of a specialized structure with condensed mesenchyme that eventually forms the dermal hair papilla. Investigations in mouse embryos also strongly indicate that induction/growth of skin structures is dependent on platelet-derived growth factor (PDGF) alpha-receptor expression in the mesenchyme. We therefore investigated the expression of PDGF A and B chain and PDGF alpha and beta receptors in basal cell carcinoma and in normal skin by immunohistochemistry and in situ hybridization. alpha and beta receptors were found in the specific stroma components of basal cell carcinoma, dermal hair papilla, and sweat glands, but not in the epithelial structures. The A and B chains, on the other hand, were mainly found in basal cell carcinoma cells, in hair matrix, and in sweat gland epithelium. This "appositional" expression of PDGF/PDGF receptor closely resembles that found in epithelial/mesenchymal structures during normal development. The findings also suggest that PDGF receptor expression is one of the characteristics of the specific stroma that is necessary for basal cell carcinoma growth.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8120413     DOI: 10.1111/1523-1747.ep12371787

Source DB:  PubMed          Journal:  J Invest Dermatol        ISSN: 0022-202X            Impact factor:   8.551


  13 in total

Review 1.  Incidence and risk of hand-foot skin reaction with cabozantinib, a novel multikinase inhibitor: a meta-analysis.

Authors:  V R Belum; C Serna-Tamayo; S Wu; M E Lacouture
Journal:  Clin Exp Dermatol       Date:  2015-05-25       Impact factor: 3.470

2.  Osteopontin stimulates preneoplastic cellular proliferation through activation of the MAPK pathway.

Authors:  Xianmin Luo; Megan K Ruhland; Ermira Pazolli; Anne C Lind; Sheila A Stewart
Journal:  Mol Cancer Res       Date:  2011-06-14       Impact factor: 5.852

Review 3.  Kinase inhibitors in cancer therapy: a look ahead.

Authors:  H H Sedlacek
Journal:  Drugs       Date:  2000-03       Impact factor: 9.546

4.  A role of PDGFRalpha in basal cell carcinoma proliferation.

Authors:  J Xie; M Aszterbaum; X Zhang; J M Bonifas; C Zachary; E Epstein; F McCormick
Journal:  Proc Natl Acad Sci U S A       Date:  2001-07-31       Impact factor: 11.205

5.  Tumorigenic conversion of immortal human keratinocytes through stromal cell activation.

Authors:  M Skobe; N E Fusenig
Journal:  Proc Natl Acad Sci U S A       Date:  1998-02-03       Impact factor: 11.205

6.  Fibroblast-dependent induction of a murine skin lesion with similarity to human common blue nevus.

Authors:  S M Prouty; L Lawrence; K S Stenn
Journal:  Am J Pathol       Date:  1996-06       Impact factor: 4.307

Review 7.  Cytokines in tumour growth, migration and metastasis.

Authors:  R P Negus; F R Balkwill
Journal:  World J Urol       Date:  1996       Impact factor: 4.226

Review 8.  The risk of hand foot skin reaction to pazopanib, a novel multikinase inhibitor: a systematic review of literature and meta-analysis.

Authors:  Yevgeniy Balagula; Shenhong Wu; Xiao Su; Darren R Feldman; Mario E Lacouture
Journal:  Invest New Drugs       Date:  2011-03-11       Impact factor: 3.850

9.  Risk of hand-foot skin reaction with the novel multikinase inhibitor regorafenib: a meta-analysis.

Authors:  Viswanath Reddy Belum; Shenhong Wu; Mario E Lacouture
Journal:  Invest New Drugs       Date:  2013-05-23       Impact factor: 3.850

10.  Coexpression of hepatocyte growth factor and receptor (Met) in human breast carcinoma.

Authors:  A B Tuck; M Park; E E Sterns; A Boag; B E Elliott
Journal:  Am J Pathol       Date:  1996-01       Impact factor: 4.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.